Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

View the 50 largest pharmaceutical companies in the world listings here

Sanofi logo

Sanofi

Rank: 8

2022 Rank: 10

Paris, France
www.sanofi.com

2022 Revenues ($USD) : $45,293,039,800.00
2022 Revenues (foreign currencies) : €42,997,000,000
2022 R&D spend : $7,064,100,400.00
2022 Number of Employees : 91,573
Fiscal Year End : 12/31/22
Leader : CEO Paul Hudson

Sanofi's 2022 performance showcased significant progress in transforming its R&D organization while maintaining strong operational and financial outcomes. The company's specialty care sector, driven by Dupixent, delivered the highest sales among its businesses, reaching €10 billion in 2023. In 2022, the company launched two new molecular entities, Xenpozyme and Enjaymo, and continued to lead in the vaccine market with a focus on pediatric vaccines. Sanofi's 2022 earnings per share grew by 17.1% at constant exchange rates, and its R&D efforts achieved multiple publications in peer-reviewed medical journals. The company is poised for further growth in 2023 with two major launches, ALTUVIIIO for Hemophilia A and Beyfortus for RSV prevention. —BB
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE